Molecular characterization of the microsomal tamoxifen binding site (Q44919464)

7 December 2017

title

Molecular characterization of the microsomal tamoxifen binding site (English)

1 reference

7 December 2017

1 reference

1 reference

7 December 2017

Blandine Kedjouar

1 reference

7 December 2017

Philippe de Médina

1 reference

7 December 2017

Mustapha Oulad-Abdelghani

1 reference

7 December 2017

Bruno Payré

1 reference

7 December 2017

Sandrine Silvente-Poirot

1 reference

7 December 2017

Gilles Favre

1 reference

7 December 2017

Jean-Charles Faye

1 reference

7 December 2017

language of work or name

English

0 references

publication date

2 June 2004

1 reference

Journal of Biological Chemistry

7 December 2017

published in

1 reference

7 December 2017

volume

279

1 reference

7 December 2017

1 reference

7 December 2017

page(s)

34048-34061

1 reference

Tamoxifen: a most unlikely pioneering medicine

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

Comparative affinity of steroidal and non-steroidal antioestrogens, cholesterol derivatives and compounds with a dialkylamino side chain for the rat liver antioestrogen binding site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

Further evidence for a biological role of anti-estrogen-binding sites in mediating the growth inhibitory action of diphenylmethane derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

Modifications of benzylphenoxy ethanamine antiestrogen molecules: influence affinity for antiestrogen binding site (AEBS) and cell cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

Structural similitudes between cytotoxic antiestrogen-binding site (AEBS) ligands and cytotoxic sigma receptor ligands. Evidence for a relationship between cytotoxicity and affinity for AEBS or sigma-2 receptor but not for sigma-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

Phase III study of N,N-diethyl-2-[4-(phenylmethyl) phenoxy]ethanamine (BMS-217380-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA.19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

Identification of two tamoxifen target proteins by photolabeling with 4-(2-morpholinoethoxy)benzophenone

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

The functional expression of sodium-dependent bile acid transport in Madin-Darby canine kidney cells transfected with the cDNA for microsomal epoxide hydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

Purification, cloning, and expression of a human enzyme with acyl coenzyme A: cholesterol acyltransferase activity, which is identical to liver carboxylesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

Markedly inhibited 7-dehydrocholesterol-delta 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

Phenylalkylamine Ca2+ antagonist binding protein. Molecular cloning, tissue distribution, and heterologous expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

Molecular cloning and expression of the human delta7-sterol reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

DNA sequencing with chain-terminating inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

The anti-proliferative properties of 4-benzylphenoxy ethanamine derivatives are mediated by the anti-estrogen binding site (ABS), whereas the anti-estrogenic effects of trifluopromazine are not.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

Tamoxifen is a potent inhibitor of cholesterol esterification and prevents the formation of foam cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

An evaluation of the role of antiestrogen-binding sites in mediating the growth modulatory effects of antiestrogens: studies using t-butylphenoxyethyl diethylamine, a compound lacking affinity for the estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

Effect of the structure of natural sterols and sphingolipids on the formation of ordered sphingolipid/sterol domains (rafts). Comparison of cholesterol to plant, fungal, and disease-associated sterols and comparison of sphingomyelin, cerebrosides, a

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

X-ray structure of the hRORalpha LBD at 1.63 A: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

Identification of natural ligands of retinoic acid receptor-related orphan receptor α ligand-binding domain expressed in Sf9 cells––a mass spectrometry approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

27-Hydroxylation of 7- and 8-dehydrocholesterol in Smith-Lemli-Opitz syndrome: a novel metabolic pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

Cholesterol autoxidation 1981-1986.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

Review of progress in sterol oxidations: 1987-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

High-affinity anti-oestrogen binding site distinct from the oestrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405230200

21 January 2018

Identifiers

DOI

10.1074/JBC.M405230200

1 reference

7 December 2017

1 reference